(2025) Doxorubicin-induced cardiometabolic disturbances: what can we do? Frontiers in clinical diabetes and healthcare. p. 1537699. ISSN 2673-6616 (Electronic) 2673-6616 (Linking)
Full text not available from this repository.
Official URL: https://www.ncbi.nlm.nih.gov/pubmed/40027901
| Item Type: | Article |
|---|---|
| Keywords: | Glut cardiometabolic chemotherapy doxorubicin glucose insulin resistance metabolism myocardium commercial or financial relationships that could be construed as a potential conflict of interest. |
| Page Range: | p. 1537699 |
| Journal or Publication Title: | Frontiers in clinical diabetes and healthcare |
| Journal Index: | Pubmed |
| Volume: | 6 |
| Identification Number: | https://doi.org/10.3389/fcdhc.2025.1537699 |
| ISSN: | 2673-6616 (Electronic) 2673-6616 (Linking) |
| Depositing User: | خانم ناهید ضیائی |
| URI: | http://eprints.mui.ac.ir/id/eprint/31426 |
Actions (login required)
 |
View Item |